Cellular allo reactivity against paternal HLA antigens in normal multiparous females as detected by intracellular cytokine flow cytometry remains elevated over years despite diminution of anti-HLA antibody levels

Transplant Immunology

Volumn 23, Issue 3, 2010, Pages 133-140

  Toyoda, Mieko ^a   Ge, Shili ^a   Pao, Andy ^a   Vo, Ashley ^a   Deer, Nathan ^a   Aguiluz, Angela ^a   Karasyov, Artur ^a   Jordan, Stanley C ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cellular immunity; Paternal HLA; Pregnancy; Sensitization

Indexed keywords

ALLOANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA ANTIBODY; HLA ANTIGEN;

ALLOIMMUNITY; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MALE; MEMORY CELL; MULTIPARA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SENSITIZATION;

ANTIGENS, CD3; ANTIGENS, CD8; CELL SEPARATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; IMMUNIZATION; INTERFERON-GAMMA; ISOANTIBODIES; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MALE; PARITY; PREGNANCY; T-LYMPHOCYTES;

EID: 77953915564     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.05.004     Document Type: Article

References (37)

1. Jordan S.C., Tyan D., Stablein D., McIntosh M., Rose S., Vo A., et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 2004, 15(12):3256-3262.
2. Jordan S.C., Vo A.A., Peng A., Toyoda M., Tyan D. Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients. Am J Transplant 2006, 6(3):459-466.
3. Glotz D., Antoine C., Julia P., Suberbielle-Boissel C., Boudjeltia S., Fraoui R., et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant 2002, 2(8):758-760.
4. Montgomery R.A., Zachary A.A., Racusen L.C., Leffell M.S., King K.E., Burdick J., et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000, 70(6):887-895.
5. Gloor J.M., DeGoey S., Ploeger N., Gebel H., Bray R., Moore S.B., et al. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 2004, 78(2):221-227.
6. Vo A.A., Lukovsky M., Toyoda M., Wang J., Reinsmoen N.L., Lai C.H., et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008, 359(3):242-251.
7. Vo A.A., Toyoda M., Peng A., Bunnapradist S., Lukovsky M., Jordan S.C. Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG. Am J Transplant 2006, 6(10):2384-2390.
8. Akalin E., Bromberg J.S. Intravenous immunoglobulin induction treatment in flow cytometry cross-match-positive kidney transplant recipients. Hum Immunol 2005, 66(4):359-363.
9. Terasaki P.I., Cai J. Humoral theory of transplantation: further evidence. Curr Opin Immunol 2005, 17(5):541-545.
10. Rifle G., Mousson C., Martin L., Guignier F., Hajji K. Donor-specific antibodies in allograft rejection: clinical and experimental data. Transplantation 2005, 79(3 Suppl):S14-S18.
11. Pescovitz M.D. B cells: a rational target in alloantibody-mediated solid organ transplantation rejection. Clin Transpl 2006, 20(1):48-54.
12. Martin L., Guignier F., Mousson C., Rageot D., Justrabo E., Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003, 76(2):395-400.
13. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transpl 2005, 19(Suppl 14):76-85.
14. Reinsmoen N.L., Lai C.H., Vo A., Cao K., Ong G., Naim M., et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation 2008, 86(6):820-825.
15. Toyoda M., Pao A., Vo A., Lukovsky M., Radha R., Sado T., et al. Intracellular IFNgamma production in CD3 negative cells exposed to allo-antigens is an indicator of prior sensitization. Transpl Immunol 2010, 22:121-127.
16. van Kampen C.A., Versteeg-vd Voort Maarschalk M.F., Langerak-Langerak J., Roelen D.L., Claas F.H. Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child. Hum Immunol 2002, 63(6):452-458.
17. Van Rood J.J., Eernisse J.G., Van Leeuwen A. Leucocyte antibodies in sera from pregnant women. Nature 1958, 181(4625):1735-1736.
18. Suciu-Foca N., Reed E., Rohowsky C., Kung P., King D.W. Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci USA 1983, 80(3):830-834.
19. Reed A., Pirsch J., Armbrust M.J., Burlingham W.J., Knechtle S.J., D'Alessandro A.M., et al. Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants. Transplantation 1991, 51(2):382-384.
20. Qian Z., Lee C.Y., Murata K., Liu J., Fox-Talbot K., Wasowska B.A., et al. Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion. Transplantation 2006, 82(7):857-864.
21. Terasaki P.I., Cecka J.M., Gjertson D.W., Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995, 333(6):333-336.
22. Pollack M.S., Trimarchi H.M., Riley D.J., Casperson P.R., Manyari L.E., Suki W.N. Shared cadaver donor-husband HLA class I mismatches as a risk factor for renal graft rejection in previously pregnant women. Hum Immunol 1999, 60(11):1150-1155.
23. Rosenberg J.C., Jones B., Oh H. Accelerated rejection following offspring-to-mother and husband-to-wife transplants. Clin Transpl 2004, 18(6):729-733.
24. van den Boogaardt D.E., van Rood J.J., Roelen D.L., Claas F.H. The influence of inherited and noninherited parental antigens on outcome after transplantation. Transpl Int 2006, 19(5):360-371.
25. van Kampen C.A., Versteeg-van der Voort Maarschalk M.F., Langerak-Langerak J., van Beelen E., Roelen D.L., Claas F.H. Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol 2001, 62(3):201-207.
26. Toyoda M., Zhang X.M., Petrosian A., Wachs K., Moudgil A., Jordan S.C. Inhibition of allospecific responses in the mixed lymphocyte reaction by pooled human gamma-globulin. Transpl Immunol 1994, 2(4):337-341.
27. El-Awar N.R., Akaza T., Terasaki P.I., Nguyen A. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. Transplantation 2007, 84(4):532-540.
28. El-Awar N., Lee J.H., Tarsitani C., Terasaki P.I. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. Hum Immunol 2007, 68(3):170-180.
29. van Kampen C.A., Roelen D.L., Versteeg-van der Voort Maarschalk M.F., Hoitsma A.J., Allebes W.A., Claas F.H. Activated HLA class I-reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failure. Transplantation 2002, 74(8):1114-1119.
30. Sun J.C., Beilke J.N., Lanier L.L. Adaptive immune features of natural killer cells. Nature 2009, 457(7229):557-561. PMCID: 2674434.
31. O'Leary J.G., Goodarzi M., Drayton D.L., von Andrian U.H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006, 7(5):507-516.
32. Mulder A., Kardol M.J., Kamp J., Uit Het Broek C., Schreuder G.M., Doxiadis I.I., et al. Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals. Clin Exp Immunol 2001, 124(1):9-15. PMCID: 1906029.
33. Mulder A., Eijsink C., Kardol M.J., Franke-van Dijk M.E., van der Burg S.H., Kester M., et al. Identification, isolation, and culture of HLA-A2-specific B lymphocytes using MHC class I tetramers. J Immunol 2003, 171(12):6599-6603.
34. Zachary A.A., Kopchaliiska D., Montgomery R.A., Leffell M.S. HLA-specific B cells: I. A method for their detection, quantification, and isolation using HLA tetramers. Transplantation 2007, 83(7):982-988.
35. Poggio E.D., Augustine J.J., Clemente M., Danzig J.M., Volokh N., Zand M.S., et al. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation 2007, 83(7):847-852.
36. Korin Y.D., Lee C., Gjertson D.W., Wilkinson A.H., Pham T.P., Danovitch G.M., et al. A novel flow assay for the detection of cytokine secreting alloreactive T cells: application to immune monitoring. Hum Immunol 2005, 66(11):1110-1124.
37. Dankers M.K., Roelen D.L., Korfage N., de Lange P., Witvliet M., Sandkuijl L., et al. Differential immunogenicity of paternal HLA class I antigens in pregnant women. Hum Immunol 2003, 64(6):600-606.